Company news

Bristol-Myers Squibb Company news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Bristol Myers Squibb to Participate in the Bernstein 41st Annual Strategic Decisions Conference

May 21, 2025

Bristol Myers Squibb Receives European Commission Approval for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo for Resectable, High-Risk Non-Small Cell Lung Cancer with PD-L1 Expression ≥1%

May 16, 2025

Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer

May 6, 2025

Bristol Myers Squibb Reports First Quarter Financial Results for 2025

April 24, 2025

Bristol Myers Squibb Announces Topline Results from Phase 3 ARISE Trial Evaluating Cobenfy (xanomeline and trospium chloride) as an Adjunctive Treatment to Atypical Antipsychotics in Adults with Schizophrenia

April 22, 2025

← Newer news releases

Calls

The 5 newest of 31 calls. Every call is listed under its year.

Decks

The 5 newest of 64 decks. Every deck is listed under its year.